Paul G. Chaney's most recent trade in Kiora Pharmaceuticals Inc was a trade of 8,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 3, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kiora Pharmaceuticals Inc | Paul G. Chaney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 8,000 | 8,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Paul G. Chaney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 5,000 | 5,000 | - | - | Stock Option (right to buy) | |
| Kiora Pharmaceuticals Inc | Paul G. Chaney | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,333 | 3,333 | - | - | Stock Option (right to buy) |